Table 3.
Sample without Antihypertensive Medication (n = 4677) | ||||
---|---|---|---|---|
Predictor | Outcome | β (95% CI) | Ptrend | R2 |
Systolic blood pressure | ||||
PRAL (FFQ), mEq/day | Basic model a | 0.0375 (0.0094, 0.0657) | 0.009 c | 0.2059 |
Adjusted model b | 0.0375 (0.0086, 0.0664) | 0.01 c | 0.2385 | |
K-Intake (FFQ), g/day | Basic model a | −0.2648 (−0.685, 0.1553) | 0.2 | 0.2045 |
Adjusted model b | −0.2210 (−0.6379, 0.1960) | 0.3 | 0.2370 | |
K-Excretion, mmol/day | Basic model a | −0.0128 (−0.0257, 0.0002) | 0.05 | 0.2050 |
Adjusted model b | −0.0280 (−0.0420, −0.0140) | 0.0001 c | 0.2406 | |
Diastolic blood pressure | ||||
PRAL (FFQ), mEq/day | Basic model a | 0.0068 (−0.0119, 0.0256) | 0.5 | 0.1878 |
Adjusted model b | 0.0064 (−0.0129, 0.0258) | 0.5 | 0.2132 | |
K-Intake (FFQ), g/day | Basic model a | −0.1954 (−0.4718, 0.0810) | 0.2 | 0.1882 |
Adjusted model b | −0.1880 (−0.4597, 0.0836) | 0.2 | 0.2136 | |
K-Excretion, mmol/day | Basic model a | −0.0085 (−0.0167, −0.0002) | 0.04 c | 0.1886 |
Adjusted model b | −0.0144 (−0.0238, −0.0049) | 0.003 c | 0.2154 |
a Adjusted for age, sex, and BMI; b Basic model, additionally adjusted for size of BP cuff, fasting duration (> or <8 h), smoking status, natrium excretion, alcohol intake, eGFR, serum glucose, and total cholesterol; c Bold numbers indicate significant p-values (<0.05); PRAL, potential renal acid load; DEGS1, German Health-Interview and Examination Survey for Adults; CI, confidence interval; FFQ, food frequency questionnaire; BMI, body mass index; eGFR, estimated glomerular filtration rate calculated according to the four-variable MDRD formula.